| Welcome to FierceLifeSci Weekly Digest, your roundup of the biggest and most popular stories from each of our publications. | |
|
Featured Story | | | Friday, January 19, 2018 Sanofi's already-hit U.S. diabetes and cardiovascular sales team is set for another round of layoffs. |
|
|
| This week's sponsor is Cardinal Health OptiFreight Logistics. | | | [Webinar] Best Practices for Shipping Pharmaceuticals to Your Patients
Tuesday, January 30 | 2pm ET / 11am PT
Pharmacies spend thousands on shipping annually. As shipping and logistics can become cumbersome, they pay little attention to more cost-effective options. Find out how to free up time and stay focused on patient needs while improving your bottom line. Register now! |
Top Stories Of The Week Monday, January 22, 2018 Celgene has agreed to buy CAR-T specialist Juno Therapeutics for around $9 billion in a deal that instantly makes it a big cheese in this emerging therapeutic category. Monday, January 22, 2018 Sanofi has finally scored a deal. The French pharma, which has been shopping for a big add-on to bolster revenue as its diabetes business falters, will shell out $11.6 billion for Bioverativ, the hemophilia-focused drugmaker spun off by Biogen just last year. Tuesday, January 23, 2018 New York City is doubling down on its long-discussed, never-realized dream of building a biotech hub to rival South San Francisco and Boston. The latest iteration of the dream comes backed by a $500 million financing package and a goal to quadruple the amount of R&D space in the city. Wednesday, January 24, 2018 Rare disease biopharma Shire has kick-started a new mandatory open-access program for research manuscripts to journals it has funded. Monday, January 22, 2018 Tweeting to the top, GlaxoSmithKline and Pfizer tied for the No. 1 spot in the inaugural ranking of global pharma influencers by Owen Health. The U.K.-based healthcare marketing agency evaluated 22 pharma companies on authority, reach, activity, engagement and influence to rate the most and least adept when it comes to Twitter. Thursday, January 18, 2018 Using mass spectrometry, researchers from Sweden and the U.K. have discovered how drugs bind to the enzyme DHODH, which could lay the groundwork for more selective cancer drugs that slow or stop cell division. Tuesday, January 23, 2018 Sanofi had already agreed to refund the Philippines for unused Dengvaxia shots as part of an ongoing safety controversy there. Now an executive has told legislators the company will "shoulder the cost" of any adverse events that are scientifically linked to vaccination. Wednesday, January 24, 2018 The CMS has withdrawn a proposed rule intended to accelerate access to medical devices. Officials put the rule forward to enable earlier Medicare coverage of medical devices, only to withdraw it nine months later. Wednesday, January 24, 2018 Amneal CEO Chintu Patel says the drugmaker’s plants on Long Island, New York, are already near capacity. With a merger with pharma peer Impax Laboratories expected to close in the first half of the year, he figures the company needs even more space and employees to meet growing demand. Enrollment Showcase | | | Sponsored by: Drexel University Online Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more. |
|
|
Resources Presented by: SDC and Stiris Research What do you do when timelines are missed, data is dirty, and everyone is pointing fingers? Join this webinar to learn how to prevent, identify, and implement a successful clinical trial rescue. Presented by: Patheon Download Patheon’s whitepaper to discover two main areas where a drug developer can face significant obstacles during biologics development and how by evaluating these capabilities, it can answer the critical question of whether its in-house strategy is ready for these uncertainties. Sponsored by: Veeva Systems Expanding into new markets places a spotlight on inefficient processes. Sponsored by: Veeva Systems Regulatory leaders share challenges and best practices from a lack of standardization, manual processes, and fragmented systems. Sponsored by: Veeva Systems Read this guide if you’re a global life sciences company - conducting clinical trials across several countries, or manufacturing and distributing products in multiple regions - to learn five steps to align and improve quality oversight, as well as avoid common mistakes in harmonization initiatives. |
